These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 21799468

  • 1. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 2. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.
    Liver Transpl; 2008 Dec 27; 14(12):1778-86. PubMed ID: 19025914
    [Abstract] [Full Text] [Related]

  • 3. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.
    Liver Transpl; 2006 Apr 27; 12(4):560-5. PubMed ID: 16555313
    [Abstract] [Full Text] [Related]

  • 4. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 27; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 5. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ, Yoo HY.
    Liver Transpl; 2004 Oct 27; 10(10):1263-8. PubMed ID: 15376301
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

  • 7. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 15; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 8. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR.
    Liver Transpl; 2012 Mar 15; 18(3):315-22. PubMed ID: 22140013
    [Abstract] [Full Text] [Related]

  • 9. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.
    Liver Transpl; 2012 Feb 15; 18(2):160-5. PubMed ID: 22006378
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.
    Transplant Proc; 2007 Dec 15; 39(10):3261-5. PubMed ID: 18089367
    [Abstract] [Full Text] [Related]

  • 11. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 12. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.
    Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623
    [Abstract] [Full Text] [Related]

  • 13. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep 15; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 14. Is recurrent hepatitis C worse with living donors?
    Kuo A, Terrault NA.
    Curr Opin Organ Transplant; 2009 Jun 15; 14(3):240-4. PubMed ID: 19395968
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.
    Liver Transpl; 2007 May 15; 13(5):687-92. PubMed ID: 17457911
    [Abstract] [Full Text] [Related]

  • 16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 17. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, Renner EL, Selzner M, Ghanekar A, Levy G, Grant DR.
    Transpl Int; 2013 Aug 15; 26(8):780-7. PubMed ID: 23746118
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
    Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-Valdecasas JC, Rimola A.
    Hepatology; 2004 Sep 15; 40(3):699-707. PubMed ID: 15349910
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group.
    Liver Transpl; 2007 Jan 15; 13(1):122-9. PubMed ID: 17192908
    [Abstract] [Full Text] [Related]

  • 20. Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation.
    Sugawara Y, Tamura S, Yamashiki N, Kaneko J, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N.
    Transplant Proc; 2012 Apr 15; 44(3):791-3. PubMed ID: 22483497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.